ChatNT: A Multimodal Conversational Agent for DNA, RNA and Protein Tasks instadeep.com/wp-content/upl…

To support the #bioeconomy and grow our collective knowledge, Ginkgo Bioworks is, for the first time, opening up access to their Foundry data with a streamlined, easy-to-use, IP-protected collaboration model. Join this session for an interactive look at how you can access some of

Something I’ve been asked but have no expense with (and this really, really is for someone else):

What’s it like to transition from a senior industrial scientific role to laboratory reagent/equipment sales?

Great things are built from small things built well

Biotech is an expensive, high-stakes game of chasing inflections.

The most successful teams start with those milestones in mind and work backwards from there: milestone > data package > experiments (iterate)

Some thoughts here: blog.kaleidoscope.bio/plan-smartly-e…

1/n Can LLMs perform scientific research? And, can they do so while enhancing key scientific values including transparency, traceability & verifiability? Check out our preprint on the 'data-to-paper' platform. w the amazing Tal Ifargan Lukas Hafner arxiv.org/abs/2404.17605

‘ChatGPT for CRISPR’ creates new gene-editing tools | Nature nature.com/articles/d4158…

Do you write a blog? If so, where do most of your readers come from?

We built CZ #CellxGene to provide the community with curated, interoperable single-cell data. Today, the platform has 85M+ cells & tools like Census that are being used to train new analysis models. Proud to see @nature highlight our work & collaborators nature.com/articles/d4158…

Come chat w us about practical lessons learned while building new types of science orgs. Or just come hang around so you can finally meet Vega Shah in person like me

I wish I heard this George Church (george church) podcast episode when I was a grad student!
1. You can change the world, as long as you don't care who gets credit.
2. The idea is not to never fail, it is to fail a million times a day.
3. Embrace the outlier!
nightscience.buzzsprout.com/1744020/149731…

GLP-1 drug rides again.......
Among 51 people with metabolic dysfunction-associated steatotic liver disease (MASH, MASLD) with HIV, 15 (29%) had complete resolution and 30 (58%) had >30% reduction of liver fat
acpjournals.org/doi/10.7326/M2…
Annals of Int Med

I just published: More on toxic academia: does investing time in outreach, mentoring and community activities matter?

Outreach, mentoring, and community support are crucial for fostering a positive academic environment. Yet some established academics dismiss their importance,…

We added new panelists since I last posted about this. I am looking forward to moderating a panel at SynBioBeta on how unique funding models can support research that falls outside the academic and for-profit realms.

I'll be talking to seemay chou from ArcadiaScience,

Young scientists regularly ask me for career advice. Academia or industry? Big company or startup? US or Europe?  Good scientists in AI disciplines are fortunate to have many choices. But choosing can be stressful. I always give the same advice. 1/10

Can’t get over these amazing stickers from Pacific Northwest National Laboratory

Always handy to have a negative strip of Western blot that you can use four times in the same figure!

One of the corresponding authors is a Nobel Prize winner Stanford University, the other one works Scripps Research.

#ImageForensics
pubpeer.com/publications/2…

I really wonder about standalone software firms

Some areas like LIMS etc seem to do quite well

Some areas like selling analysis seem to really struggle

I feel like many life scientists don’t budget for software so many analyses software have to be bundled in with reagents